How Weisblum was paid
$630,051 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Other | Total |
|---|---|---|---|---|
| Eric WeisblumChief Executive Officer | $350,000 | $200,000 | $80,051 | $630,051 |
| Daniel RyweckChief Financial Officer | $60,000 | $25,000 | $3,600 | $88,600 |
What changed and why
- $630K$630,051 was CEO Eric Weisblum’s 2024 total compensation, up from $569,009 in 2023.
- $200K$200,000 was Weisblum’s 2024 bonus, against a discretionary annual bonus opportunity of up to $350,000.
- $80,051$80,051 of Weisblum’s compensation comprised 401(k) contributions and health insurance premiums.
- $88,600$88,600 was CFO Daniel Ryweck’s 2024 total compensation, including a $25,000 bonus.
- $60,000$60,000 is Ryweck’s annual base salary, with discretionary bonus eligibility of up to $60,000.
- $700K$700,000 is Weisblum’s stated potential termination payment, representing 24 months of base salary.
Other Silo Pharma proxy statements
- 2026 proxy statement
Eric Weisblum paid $521,750 (-17% on the year).
Filed Jun 30, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.